Free Trial
ASX:AC8

AusCann Group (AC8) Stock Price, News & Analysis

About AusCann Group Stock (ASX:AC8)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
537,446 shs
Average Volume
N/A
Market Capitalization
A$17.62 million
P/E Ratio
N/A
Dividend Yield
6.79%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AC8 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AusCann Group and its competitors with MarketBeat's FREE daily newsletter.

AC8 Stock News Headlines

AusCann Group Holdings Ltd (ACNNF)
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
AC8.AX - AusCann Group Holdings Ltd
ACNNF AusCann Group Holdings Ltd
See More Headlines

AC8 Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that AusCann Group investors own include 3D Systems (DDD), Bristol Myers Squibb (BMY), Johnson & Johnson (JNJ), Workday (WDAY), Zoom Communications (ZM), Zynerba Pharmaceuticals (ZYNE) and Ambarella (AMBA).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
ASX:AC8
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$9.44 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-1.09%
Return on Assets
-1.67%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
33.22
Quick Ratio
20.17

Sales & Book Value

Annual Sales
A$1.36 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
2.05
Book Value
A$0.01 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
440,550,000
Free Float
N/A
Market Cap
A$17.62 million
Optionable
Not Optionable
Beta
0.72
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (ASX:AC8) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners